SPRY

SPRY Operating Income Growth

-264.44%TTM

Period ending:

SPRY TTM Operating Income YoY %%
SPRY TTM Operating Income YoY %793.35%-6418.48%
2021-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

SPRY operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 19 observations from Dec 31, 2021 to Jun 30, 2026.

Ars Pharmaceuticals Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-264.4417%
-647.8055%
-5,720.5644%
-50.0446%
-4.5932%
56.3412%
95.4339%
16.8154%
7.5795%
-31.5489%
-90.1115%
-190.5528%
-155.5745%
-113.1181%
-82.564%
9.2774%
15.5445%
24.3807%
38.7025%

Compare operating income growth

All SPRY financial metrics · SPRY stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.